Correlation Between TaiMed Biologics and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TaiMed Biologics and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TaiMed Biologics and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TaiMed Biologics and Medigen Vaccine Biologics, you can compare the effects of market volatilities on TaiMed Biologics and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TaiMed Biologics with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of TaiMed Biologics and Medigen Vaccine.

Diversification Opportunities for TaiMed Biologics and Medigen Vaccine

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between TaiMed and Medigen is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding TaiMed Biologics and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and TaiMed Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TaiMed Biologics are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of TaiMed Biologics i.e., TaiMed Biologics and Medigen Vaccine go up and down completely randomly.

Pair Corralation between TaiMed Biologics and Medigen Vaccine

Assuming the 90 days trading horizon TaiMed Biologics is expected to under-perform the Medigen Vaccine. But the stock apears to be less risky and, when comparing its historical volatility, TaiMed Biologics is 1.31 times less risky than Medigen Vaccine. The stock trades about -0.03 of its potential returns per unit of risk. The Medigen Vaccine Biologics is currently generating about 0.5 of returns per unit of risk over similar time horizon. If you would invest  3,525  in Medigen Vaccine Biologics on November 3, 2024 and sell it today you would earn a total of  1,380  from holding Medigen Vaccine Biologics or generate 39.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

TaiMed Biologics  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
TaiMed Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days TaiMed Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, TaiMed Biologics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

TaiMed Biologics and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TaiMed Biologics and Medigen Vaccine

The main advantage of trading using opposite TaiMed Biologics and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TaiMed Biologics position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind TaiMed Biologics and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum